Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
46.76
-0.07 (-0.15%)
At close: Dec 26, 2025
SHA:603392 Market Cap
SHA:603392 has a market cap or net worth of 59.16 billion as of December 26, 2025. Its market cap has decreased by -35.50% in one year.
Market Cap
59.16B
Enterprise Value
54.59B
Revenue
1.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
46.76
Market Cap Chart
Since April 29, 2020, SHA:603392's market cap has increased from 5.46B to 59.16B, an increase of 982.80%. That is a compound annual growth rate of 52.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 59.16B | -33.64% |
| Dec 31, 2024 | 89.14B | -6.44% |
| Dec 29, 2023 | 95.28B | -17.00% |
| Dec 30, 2022 | 114.80B | -14.62% |
| Dec 31, 2021 | 134.46B | 53.87% |
| Dec 31, 2020 | 87.38B | 1,499.45% |
| Apr 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 405.29B |
| WuXi AppTec | 273.05B |
| Shenzhen Mindray Bio-Medical Electronics | 241.87B |
| Sichuan Biokin Pharmaceutical | 139.78B |
| Shanghai United Imaging Healthcare | 106.87B |
| Aier Eye Hospital Group | 103.46B |
| Zhangzhou Pientzehuang Pharmaceutical., | 102.68B |
| Yunnan Baiyao Group Co.,Ltd | 101.17B |